Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Marc Gregory Balkin Insider Profile
4 Followers
Marc Gregory Balkin, Director, Ten Percent Owner at Psyence Biomedical, holds 7.46M shares in Psyence Biomedical (Ticker: PBM).
Marc Gregory Balkin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Marc Gregory Balkin's holdings
Insider Roles
Director, Ten Percent Owner
Roles that Marc Gregory Balkin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Marc Gregory Balkin
Marc Gregory Balkin's Trading History
List of latest transactions for each holding click on a transaction to see Marc Gregory Balkin's performance on stock
You May Also Like
Marc Gregory Balkin insider profile FAQ
What is the percentage of profitable transactions made by Marc Gregory Balkin?
The percentage of profitable transactions made by Marc Gregory Balkin is ―.
What is the average return per transaction made by Marc Gregory Balkin?
The average return per transaction made by Marc Gregory Balkin is ―.
What stocks does Marc Gregory Balkin hold?
Marc Gregory Balkin holds: PBM stocks.
What was Marc Gregory Balkin’s latest transaction?
Marc Gregory Balkin latest transaction was an Uninformative Buy of ―.
What was Marc Gregory Balkin's most profitable transaction?
Marc Gregory Balkin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Marc Gregory Balkin's role in Psyence Biomedical?
Marc Gregory Balkin's role in Psyence Biomedical is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.